Importantly, we focused on tumor cell-intrinsic Axl signaling; however, the receptor is also expressed on other cell types such as immune or endothelial cells, conferring anti-inflammatory capacities, potentially complicating anti-Axl treatment. Here, AXL is linked to neoplasm.